Inovio Pharmaceuticals, Inc. is in clinical studies of its revolutionary DNA vaccine technology focused on extending the profound benefits of the 20th century’s vaccines by preventing and treating today’s cancers and challenging infectious diseases." lang="en-US" />
About Us
home » about us » leadership » ng tee khiang

Biography

Ng Tee Khiang
Director, Evia Capital Partners Pte.

NG TEE KHIANG, a director since April 2009, has over 15 years of entrepreneurial and investment management experience. He is a co-founder, partner and director of multiple investment companies, including, since 2004, Evia Capital Partners Pte. Ltd. and Evia Growth Opportunities Ltd. He has also been chairman and director of CNT Health Food Pte. Ltd., a nutraceutical supplements contract manufacturer, since 2000. In these positions, he has focused on seed, pre-IPO, and IPO investment opportunities. From 2002 through 2006, Mr. Ng served as a director of Asia Growth Opportunities Ltd. and Raintree Ventures, investors in Inovio. In the 1990s, he was chairman of three technology companies, Vital Technology, MediaRing Ltd., and AceFusion, helping secure seed and venture capital, guide strategic growth, and facilitate the sale or public listing of the companies.

Mr. Ng has an M.Sc. in Industrial Engineering from Stanford University.